2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethanol, 95.0%, 5g

4-Methyl-3-nitroaniline, 98.0%, 500g

6-(4-methylpiperazin-1-yl)pyridazin-3-ol, 95.0%, 500mg

(2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid, 95.0%, 25g

2-Bromo-9H-xanthen-9-one, 95.0%, 25g

EXO-2-BROMONORBORNANE, 97.0%, 1g

2-Fluoro-4-methyl-6-nitrophenol, 95.0%, 100mg

BATIMASTAT, 95%, 100mg

4-(2-Chloro-6-methyl-pyrimidin-4-yl)-piperazine-1-carboxylic acid tert-butyl ester, 98.0%, 100mg

1-Hydroxyethane-(1,1-diphosphonic acid), (HEDP), min. 90%, 500 g, plastic packaging.

3-Amino-3-(4-methoxy-3-methylphenyl)propanoic acid, 97%, 2.5g

(3R,4S)-1-((4-Amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4-((methylthio)methyl)pyrrolidin-3-ol, 98%, 5mg

N-1H-benzimidazol-2-yl-2-chloroacetamide, 95.0%, 1g